
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Author(s) -
Amira Marouf,
AnneSégolène Cottereau,
Salim Kanoun,
P Deschamps,
Michel Meignan,
Patricia Franchi,
David Sibon,
Clara Antoine,
Thomas Gastinne,
Cécile Borel,
Mohammad Hammoud,
Guillaume Sicard,
R. Gille,
Doriane Cavalieri,
Aspasia Stamatoullas,
Lauriane FilliatreClement,
Julien Lazarovici,
Adrien Chauchet,
LucMatthieu Fornecker,
Sandy Amorin,
Mathieu Rocquet,
Nicole Raus,
Barbara Burroni,
Marie Thérèse Rubio,
Didier Bouscary,
Philippe Quittet,
Olivier Casasnovas,
Pauline Brice,
Hervé Ghesquières,
Jérôme Tamburini,
Bénédicte Deau
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279564
Subject(s) - brentuximab vedotin , medicine , autologous stem cell transplantation , oncology , observational study , transplantation , refractory (planetary science) , stem cell , cohort , lymphoma , hematopoietic stem cell transplantation , cohort study , chemotherapy , hodgkin lymphoma , surgery , physics , astrobiology , genetics , biology
Not available.